Literature DB >> 23922546

Emerging infectious threats to the blood supply: seroepidemiological studies in iran - a review.

Gharib Karimi1, Ahmad Gharehbaghian, Mohammad Fallah Tafti, Vida Vafaiyan.   

Abstract

SUMMARY: The risk of transfusion-transmitted infections has been greatly reduced by improvements in donor screening and testing. However, newly recognized blood-borne infectious agents can be threats to blood safety. In order to evaluate the prevalence some of these agents in blood donors, a systematic review was conducted. Data were obtained from published papers related to HGV, Torque Teno virus (TTV), HTLV, West Nile virus (WNV) and SEN virus (SEN-V). Based on these studies, the prevalence of HGV varied from 1 to 8.6% for anti-E2 and from 0 to 4.8% for HGV RNA. The prevalence of TTV DNA and HTLV-I varied from 2.7 to 79.5% and from 0.013 to 2.3%, respectively. The WNV-specific IgM antibody and WNV RNA are negative in blood donors. Prevalence rates of SEN-V in Iranian blood donors range from 23 to 90.8%. Consequences of these infectious agents for blood safety are different. Thus, the need to perform laboratory screening as well as effectiveness and efficiency of laboratory tests depend on pathogenicity level and epidemiological conditions of emerging infections. However, being prepared based on the current level of risk and interventions to reduce the risk can be effective in reducing the potential threat for blood supply.

Entities:  

Keywords:  Blood supply; Emerging; Infectious diseases; Iran

Year:  2013        PMID: 23922546      PMCID: PMC3725032          DOI: 10.1159/000351540

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  76 in total

1.  Influence of primers on the detection of TT virus DNA by polymerase chain reaction.

Authors:  K Itoh; M Takahashi; M Ukita; T Nishizawa; H Okamoto
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

2.  High prevalence of TT virus DNA in human saliva and semen.

Authors:  T Inami; N Konomi; Y Arakawa; K Abe
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Hepatitis G virus (HGV) infection in voluntary and commercial blood donors in India.

Authors:  P Kar; P Bedi; N Berry; A Chakravorty; R K Gupta; R Saha; B C Das
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

4.  Prevalence and phylogenetic characterisation of TT-virus in the blood donor population of Auckland, New Zealand.

Authors:  A M Werno; Z Wang; B A Schroeder; G Woodfield; M C Croxson
Journal:  J Med Virol       Date:  2000-09       Impact factor: 2.327

5.  Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants.

Authors:  R Handajani; M I Lusida; P Suryohudoyo; P Adi; P B Setiawan; C A Nidom; R Soemarto; Y Katayama; M Fujii; H Hotta
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Prevalence of the newly described human circovirus, TTV, in United States blood donors.

Authors:  A Handa; B Dickstein; N S Young; K E Brown
Journal:  Transfusion       Date:  2000-02       Impact factor: 3.157

7.  Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.

Authors:  S A Nordbø; S Krokstad; P Winge; F E Skjeldestad; A B Dalen
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  Transfusion-associated TT virus infection and its relationship to liver disease.

Authors:  A Matsumoto; A E Yeo; J W Shih; E Tanaka; K Kiyosawa; H J Alter
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

9.  TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea.

Authors:  T Nakano; Y M Park; M Mizokami; J Y Choi; E Orito; T Ohno; T Kato; Y Kondo; Y Tanaka; H Kato; T Kato; B S Kim
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

10.  Prevalence of GBV C/HGV RNA and GBV C/HGV antibodies in French volunteer blood donors: results of a collaborative study.

Authors:  B Mercier; A Barclais; C Botte; J Cantalube; J Coste; C Defer; C Gautreau; C Giannoli; P Halfon; I Lepot; P Loiseau; J Martial; P Montcharmont; P Merel; D Ouzan; N Ravera; J Follana; R Césaire; C Janot; J Lemaire; P De Micco; G Vezon; C Férec
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

View more
  4 in total

Review 1.  Prevalence of Toxoplasma gondii among Iranian Blood Donors: A Narrative Review Article.

Authors:  Gharib Karimi; Ahmad Mardani; Maryam Zadsar
Journal:  Iran J Parasitol       Date:  2016 Jan-Mar       Impact factor: 1.012

2.  Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.

Authors:  Gharib Karimi; Maryam Zadsar; Ali Akbar Pourfathollah
Journal:  Virol J       Date:  2017-01-30       Impact factor: 4.099

3.  Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.

Authors:  Le Chang; Shanhai Ou; Zhengang Shan; Faming Zhu; Huimin Ji; Xia Rong; Fei Guo; Xinyi Jiang; Huizhen Sun; Ying Yan; Lunan Wang
Journal:  Retrovirology       Date:  2021-01-07       Impact factor: 4.602

4.  Prevalence of Torque teno virus in healthy donors of Paraná State, southern Brazil.

Authors:  Jocimara Costa Mazzola; Patrícia Keiko Saito; Roger Haruki Yamakawa; Maria Angélica Ehara Watanabe; Waldir Veríssimo da Silva Junior; Alessandra Cristina Gobbi Matta; Sueli Donizete Borelli
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.